2024 |
Glenmark Pharmaceuticals Ltd.
|
Chairman & Managing Director |
16.9 Cr |
4.2 % |
2023 |
Glenmark Pharmaceuticals Ltd.
|
Chairman / Executive Director / M D / Promoter |
16.2 Cr |
2.5 % |
2023 |
Alivus Life Sciences Ltd.
|
Chairman & Non Executive Director |
- |
- |
2022 |
Glenmark Pharmaceuticals Ltd.
|
Chairman & Managing Director |
15.8 Cr |
14.0 % |
2022 |
Alivus Life Sciences Ltd.
|
Chairman & Non Executive Director |
- |
- |
2021 |
Glenmark Pharmaceuticals Ltd.
|
Chairman & Managing Director |
13.9 Cr |
13.3 % |
2021 |
Alivus Life Sciences Ltd.
|
Chairman & Non Executive Director |
- |
- |
2020 |
Glenmark Pharmaceuticals Ltd.
|
Chairman & Managing Director |
12.2 Cr |
-22.1 % |
2019 |
Glenmark Pharmaceuticals Ltd.
|
Chairman & Managing Director |
15.7 Cr |
-2.8 % |
2018 |
Glenmark Pharmaceuticals Ltd.
|
Chairman & Managing Director |
16.2 Cr |
14.6 % |
2017 |
Glenmark Pharmaceuticals Ltd.
|
Chairman & Managing Director |
14.1 Cr |
30.0 % |
2016 |
Glenmark Pharmaceuticals Ltd.
|
Chairman & Managing Director |
10.8 Cr |
29.7 % |
2015 |
Glenmark Pharmaceuticals Ltd.
|
Chairman & Managing Director |
8.4 Cr |
15.0 % |
2014 |
Glenmark Pharmaceuticals Ltd.
|
Chairman & Managing Director |
7.3 Cr |
21.3 % |
2013 |
Glenmark Pharmaceuticals Ltd.
|
Chairman and MD & CEO |
6.0 Cr |
3.1 % |
2012 |
Glenmark Pharmaceuticals Ltd.
|
Chairman and MD & CEO |
5.8 Cr |
80.2 % |
2011 |
Glenmark Pharmaceuticals Ltd.
|
Chairman and MD & CEO |
3.2 Cr |
53647.2 % |
2010 |
Glenmark Pharmaceuticals Ltd.
|
Chairman and MD & CEO |
60 K |
-99.8 % |
2009 |
Glenmark Pharmaceuticals Ltd.
|
Managing Director & Chief Executive Officer |
3.4 Cr |
95.0 % |
2008 |
Glenmark Pharmaceuticals Ltd.
|
Managing Director & Chief Executive Officer |
1.7 Cr |
10.2 % |
2007 |
Glenmark Pharmaceuticals Ltd.
|
Managing Director & Chief Executive Officer |
1.6 Cr |
44.3 % |
2006 |
Glenmark Pharmaceuticals Ltd.
|
Managing Director & Chief Executive Officer |
1.1 Cr |
-46.5 % |
2005 |
Glenmark Pharmaceuticals Ltd.
|
Managing Director & Chief Executive Officer |
2.1 Cr |
41.3 % |
2004 |
Glenmark Pharmaceuticals Ltd.
|
Managing Director & Chief Executive Officer |
1.5 Cr |
153.1 % |
2003 |
Glenmark Pharmaceuticals Ltd.
|
Managing Director & Chief Executive Officer |
57.5 L |
117.4 % |
2002 |
Glenmark Pharmaceuticals Ltd.
|
Managing Director & Chief Executive Officer |
26.5 L |
- |